Abstract
AMPK is an evolutionary conserved energy sensor involved in the regulation of energy metabolism. Based on biochemical studies, AMPK has brought much of interest in recent years due to its potential impact on metabolic disorders. Suitable animal models are therefore essential to promote our understanding of the molecular and functional roles of AMPK but also to bring novel information for the development of novel therapeutic strategies. The organism systems include pig (Sus scrofa), mouse (Mus musculus), fly (Drosophila melanogaster), worm (Caenorhabditis elegans), and fish (Danio rerio) models. These animal models have provided reliable experimental evidence demonstrating the crucial role of AMPK in the regulation of metabolism but also of cell polarity, autophagy, and oxidative stress. In this chapter, we update the new development in the generation and application of animal models for the study of AMPK biology. We also discuss recent breakthroughs from studies in mice, flies, and worms showing how AMPK has a primary role in initiating or promoting pathological or beneficial impact on health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ahmad F et al (2005) Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy. Circulation 112(20):3140–3148
Akman HO et al (2007) Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase. Pediatr Res 62(4):499–504
Andreelli F et al (2006) Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology 147(5):2432–2441
Apfeld J et al (2004) The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev 18(24):3004–3009
Arad M et al (2002) Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 109(3):357–362
Arad M et al (2003) Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 107(22):2850–2856
Arad M et al (2005) Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352(4):362–372
Banerjee SK et al (2007) A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia. Biochem Biophys Res Commun 360(2):381–387
Banerjee SK et al (2010a) Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation. Biochim Biophys Acta 1802(2):284–291
Banerjee SK et al (2010b) SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy. J Mol Cell Cardiol 49(4):683–692
Barnes BR et al (2004) The 5′-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem 279(37):38441–38447
Barnes BR et al (2005) Changes in exercise-induced gene expression in 5′-AMP-activated protein kinase gamma3-null and gamma3 R225Q transgenic mice. Diabetes 54(12):3484–3489
Barre L et al (2007) Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation. Am J Physiol 292(3):E802–E811
Baylis HA, Vazquez-Manrique RP (2011) Reverse genetic strategies in Caenorhabditis elegans: towards controlled manipulation of the genome. ScientificWorldJournal 11:1394–1410
Bayrak F et al (2006) Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation. Eur J Heart Fail 8(7):712–715
Blagih J et al (2015) The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity 42(1):41–54
Blair E et al (2001) Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 10(11):1215–1220
Bland ML et al (2010) AMPK supports growth in Drosophila by regulating muscle activity and nutrient uptake in the gut. Dev Biol 344(1):293–303
Boulin T, Hobert O (2012) From genes to function: the C. elegans genetic toolbox. Wiley Interdiscip Rev Dev Biol 1(1):114–137
Buhl ES et al (2002) Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51(7):2199–2206
Burkewitz K et al (2014) AMPK at the nexus of energetics and aging. Cell Metab 20(1):10–25
Burkewitz K et al (2015) Neuronal CRTC-1 governs systemic mitochondrial metabolism and lifespan via a catecholamine signal. Cell 160(5):842–855
Burwinkel B et al (2005) Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am J Hum Genet 76(6):1034–1049
Cabreiro F et al (2013) Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153(1):228–239
Chen ZP et al (2000) AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279(5):E1202–E1206
Cheung PC et al (2000) Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J 346(Pt 3):659–669
Ciobanu D et al (2001) Evidence for new alleles in the protein kinase adenosine monophosphate-activated gamma(3)-subunit gene associated with low glycogen content in pig skeletal muscle and improved meat quality. Genetics 159(3):1151–1162
Claret M et al (2007) AMPK is essential for energy homeostasis regulation and glucose-sensing by POMC and AgRP neurons. J Clin Invest 117(8):2325–2336
Cook M et al (2012) Increased RhoA prenylation in the loechrig (loe) mutant leads to progressive neurodegeneration. PLoS One 7(9), e44440
Cook M et al (2014) Increased actin polymerization and stabilization interferes with neuronal function and survival in the AMPKgamma mutant Loechrig. PLoS One 9(2), e89847
Cool B et al (2006) Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 3(6):403–416
Costford SR et al (2007) Gain-of-function R225W mutation in human AMPKgamma(3) causing increased glycogen and decreased triglyceride in skeletal muscle. PLoS One 2(9), e903
Cunningham KA et al (2014) Loss of a neural AMP-activated kinase mimics the effects of elevated serotonin on fat, movement, and hormonal secretions. PLoS Genet 10(6), e1004394
Daniel T, Carling D (2002) Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. J Biol Chem 277(52):51017–51024
Dasgupta B, Milbrandt J (2009) AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development. Dev Cell 16(2):256–270
Dasgupta B et al (2012) The AMPK beta2 subunit is required for energy homeostasis during metabolic stress. Mol Cell Biol 32(14):2837–2848
Davies JK et al (2006) Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome. Am J Physiol 290(5):H1942–H1951
Deak P et al (1997) P-element insertion alleles of essential genes on the third chromosome of Drosophila melanogaster: correlation of physical and cytogenetic maps in chromosomal region 86E-87F. Genetics 147(4):1697–1722
Dietzl G et al (2007) A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 448(7150):151–156
Dockendorff TC et al (2000) Genetic characterization of the 44D-45B region of the Drosophila melanogaster genome based on an F2 lethal screen. Mol Gen Genet 263(1):137–143
Dzamko N et al (2010) AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance. J Biol Chem 285(1):115–122
Enfalt AC et al (1997) Estimated frequency of the RN- allele in Swedish Hampshire pigs and comparison of glycolytic potential, carcass composition, and technological meat quality among Swedish Hampshire, Landrace, and Yorkshire pigs. J Anim Sci 75(11):2924–2935
Essen-Gustavsson B et al (2011) Muscle glycogen resynthesis, signalling and metabolic responses following acute exercise in exercise-trained pigs carrying the PRKAG3 mutation. Exp Physiol 96(9):927–937
Estrade M et al (1994) Enzyme activities of glycogen metabolism and mitochondrial characteristics in muscles of RN- carrier pigs (Sus scrofa domesticus). Comp Biochem Physiol Biochem Mol Biol 108(3):295–301
Folmes KD et al (2009) Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogen. Circ Cardiovasc Genet 2(5):457–466
Fontana L et al (2010) Extending healthy life span—from yeast to humans. Science 328(5976):321–326
Foretz M et al (2010) Maintenance of red blood cell integrity by AMP-activated protein kinase alpha1 catalytic subunit. FEBS Lett 584(16):3667–3671
Foretz M et al (2011) The AMPKgamma1 subunit plays an essential role in erythrocyte membrane elasticity, and its genetic inactivation induces splenomegaly and anemia. FASEB J 25(1):337–347
Fu X et al (2013) AMP-activated protein kinase alpha1 but not alpha2 catalytic subunit potentiates myogenin expression and myogenesis. Mol Cell Biol 33(22):4517–4525
Fu X et al (2015) AMP-activated protein kinase stimulates Warburg-like glycolysis and activation of satellite cells during muscle regeneration. J Biol Chem 290(44):26445–26456
Fu X et al (2016) Obesity impairs skeletal muscle regeneration through inhibition of AMPK. Diabetes 65(1):188–200
Fujii N et al (2000) Exercise induces isoform-specific increase in 5′AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 273(3):1150–1155
Fujii N et al (2005) AMP-activated protein kinase alpha2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle. J Biol Chem 280(47):39033–39041
Fujii N et al (2007) Role of AMP-activated protein kinase in exercise capacity, whole body glucose homeostasis, and glucose transport in skeletal muscle -Insight from analysis of a transgenic mouse model. Diabetes Res Clin Pract 77(Suppl 1):S92–98
Fukuyama M et al (2012) C. elegans AMPKs promote survival and arrest germline development during nutrient stress. Biol Open 1(10):929–936
Fullerton MD et al (2013) Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat Med 19(12):1649–1654
Galic S et al (2011) Hematopoietic AMPK beta1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J Clin Invest 121(12):4903–4915
Garcia-Roves PM et al (2008) Gain-of-function R225Q mutation in AMP-activated protein kinase gamma3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle. J Biol Chem 283(51):35724–35734
Gollob MH et al (2001a) Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 344(24):1823–1831
Gollob MH et al (2001b) Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 104(25):3030–3033
Gong H et al (2011) MEF2A binding to the Glut4 promoter occurs via an AMPKalpha2-dependent mechanism. Med Sci Sports Exerc 43(8):1441–1450
Granlund A et al (2010) Effects of exercise on muscle glycogen synthesis signalling and enzyme activities in pigs carrying the PRKAG3 mutation. Exp Physiol 95(4):541–549
Granlund A et al (2011) The influence of the PRKAG3 mutation on glycogen, enzyme activities and fibre types in different skeletal muscles of exercise trained pigs. Acta Vet Scand 53:20
Greer EL et al (2007) An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol 17(19):1646–1656
Guigas B et al (2006) 5-aminoimidazole-4-carboxamide-1-{beta}-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55(4):865–874
Gundewar S et al (2009) Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res 104(3):403–411
Halseth AE et al (2002) Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations. Biochem Biophys Res Commun 294(4):798–805
Hamilton SR et al (2001) An activating mutation in the gamma1 subunit of the AMP-activated protein kinase. FEBS Lett 500(3):163–168
Hardie DG (2014) AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels. Annu Rev Nutr 34:31–55
Hedegaard J et al (2004) UDP-glucose pyrophosphorylase is upregulated in carriers of the porcine RN- mutation in the AMP-activated protein kinase. Proteomics 4(8):2448–2454
Huang LS et al (2004) Genetic variations of the porcine PRKAG3 gene in Chinese indigenous pig breeds. Genet Sel Evol 36(4):481–486
Hue L, Taegtmeyer H (2009) The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 297(3):E578–E591
Jansen G et al (1997) Reverse genetics by chemical mutagenesis in Caenorhabditis elegans. Nat Genet 17(1):119–121
Johnson EC et al (2010) Altered metabolism and persistent starvation behaviors caused by reduced AMPK function in Drosophila. PLoS One 5(9), e12799
Jorgensen SB et al (2004a) The alpha2-5′AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. Diabetes 53(12):3074–3081
Jorgensen SB et al (2004b) Knockout of the alpha2 but not alpha1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279(2):1070–1079
Kazgan N et al (2010) Identification of a nuclear export signal in the catalytic subunit of AMP-activated protein kinase. Mol Biol Cell 21(19):3433–3442
Kelly BP et al (2009) Severe hypertrophic cardiomyopathy in an infant with a novel PRKAG2 gene mutation: potential differences between infantile and adult onset presentation. Pediatr Cardiol 30(8):1176–1179
Kim M et al (2014) Mutation in the gamma2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage. Circ Res 114(6):966–975
Kohlstedt K et al (2013) AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post-transcriptional regulation of microRNA-143/145. Circ Res 112(8):1150–1158
Kone M et al (2014) LKB1 and AMPK differentially regulate pancreatic beta-cell identity. FASEB J 28(11):4972–4985
Laforet P et al (2006) A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis. Neuromuscul Disord 16(3):178–182
Lai YC et al (2014) A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators. Biochem J 460(3):363–375
Lantier L et al (2014) AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity. FASEB J 28(7):3211–3224
Lee JH et al (2007) Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 447(7147):1017–1020
Lee H et al (2008) The Caenorhabditis elegans AMP-activated protein kinase AAK-2 is phosphorylated by LKB1 and is required for resistance to oxidative stress and for normal motility and foraging behavior. J Biol Chem 283(22):14988–14993
Lee-Young RS et al (2009) Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo. J Biol Chem 284(36):23925–23934
Li FY et al (2012) Endothelium-selective activation of AMP-activated protein kinase prevents diabetes mellitus-induced impairment in vascular function and reendothelialization via induction of heme oxygenase-1 in mice. Circulation 126(10):1267–1277
Lieberthal W et al (2013) Susceptibility to ATP depletion of primary proximal tubular cell cultures derived from mice lacking either the alpha1 or the alpha2 isoform of the catalytic domain of AMPK. BMC Nephrol 14:251
Lindgren K et al (2007) Regulation of the muscle-specific AMP-activated protein kinase alpha2beta2gamma3 complexes by AMP and implications of the mutations in the gamma3-subunit for the AMP dependence of the enzyme. FEBS J 274(11):2887–2896
Lippai M et al (2008) SNF4Agamma, the Drosophila AMPK gamma subunit is required for regulation of developmental and stress-induced autophagy. Autophagy 4(4):476–486
Liu Y et al (2013) Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure. PLoS One 8(5), e64603
Loffler AS et al (2011) Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop. Autophagy 7(7):696–706
Luptak I et al (2007) Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage. J Clin Invest 117(5):1432–1439
Maarbjerg SJ et al (2009) Genetic impairment of AMPKalpha2 signaling does not reduce muscle glucose uptake during treadmill exercise in mice. Am J Physiol Endocrinol Metab 297(4):E924–E934
Mahmoud AD et al (2015) AMPK deficiency blocks the hypoxic ventilatory response and thus precipitates hypoventilation and apnea. Am J Respir Crit Care Med 193(9):1032–1043
Mair W et al (2011) Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature 470(7334):404–408
Maixner DW et al (2015) Adenosine monophosphate-activated protein kinase regulates interleukin-1beta expression and glial glutamate transporter function in rodents with neuropathic pain. Anesthesiology 122(6):1401–1413
Medina PM et al (2006) A novel forward genetic screen for identifying mutations affecting larval neuronal dendrite development in Drosophila melanogaster. Genetics 172(4):2325–2335
Merrill GF et al (1997) AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273(6 Pt 1):E1107–E1112
Milan D et al (2000) A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 288(5469):1248–1251
Mirouse V et al (2007) LKB1 and AMPK maintain epithelial cell polarity under energetic stress. J Cell Biol 177(3):387–392
Miura S et al (2009) Alpha2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise. Am J Physiol Endocrinol Metab 296(1):E47–E55
Morita H et al (2008) Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med 358(18):1899–1908
Mounier R et al (2013) AMPKalpha1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metab 18(2):251–264
Mu J et al (2001) A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7(5):1085–1094
Nakada D et al (2010) Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 468(7324):653–658
Narbonne P, Roy R (2006) Inhibition of germline proliferation during C. elegans dauer development requires PTEN, LKB1 and AMPK signalling. Development 133(4):611–619
Narbonne P, Roy R (2009) Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival. Nature 457(7226):210–214
Ng CH et al (2012) AMP kinase activation mitigates dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson’s disease. J Neurosci 32(41):14311–14317
Nilsson EC et al (2006) Opposite transcriptional regulation in skeletal muscle of AMP-activated protein kinase gamma3 R225Q transgenic versus knock-out mice. J Biol Chem 281(11):7244–7252
O’Neill HM et al (2011) AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci U S A 108(38):16092–16097
Obba S et al (2015) The PRKAA1/AMPKalpha1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMML. Autophagy 11(7):1114–1129
Onken B, Driscoll M (2010) Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One 5(1), e8758
Pan DA, Hardie DG (2002) A homologue of AMP-activated protein kinase in Drosophila melanogaster is sensitive to AMP and is activated by ATP depletion. Biochem J 367(Pt 1):179–186
Pehmoller C et al (2009) Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle. Am J Physiol Endocrinol Metab 297(3):E665–E675
Poels J et al (2012) Autophagy and phagocytosis-like cell cannibalism exert opposing effects on cellular survival during metabolic stress. Cell Death Differ 19(10):1590–1601
Poirier L et al (2008) Characterization of the Drosophila gene-switch system in aging studies: a cautionary tale. Aging cell 7(5):758–770
Porto AG et al (2016) Clinical spectrum of PRKAG2 syndrome. Circ Arrhythm Electrophysiol 9(1), e003121
Ramratnam M et al (2014) Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice. J Am Heart Assoc 3(4), e000899
Rockl KS et al (2007) Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift. Diabetes 56(8):2062–2069
Rolf J et al (2013) AMPKalpha1: a glucose sensor that controls CD8 T-cell memory. Eur J Immunol 43(4):889–896
Rubin GM, Spradling AC (1982) Genetic transformation of Drosophila with transposable element vectors. Science 218(4570):348–353
Russell RR 3rd et al (2004) AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114(4):495–503
Sag D et al (2008) Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 181(12):8633–8641
Sayers S et al (2016) Proglucagon promoter Cre-mediated AMPK deletion in mice increases circulating GLP-1 levels and oral glucose tolerance. PLoS One 11(3), e0149549
Schaffer BE et al (2015) Identification of AMPK phosphorylation sites reveals a network of proteins involved in cell invasion and facilitates large-scale substrate prediction. Cell Metab 22(5):907–921
Schertel C et al (2013) Systematic screening of a Drosophila ORF library in vivo uncovers Wnt/Wg pathway components. Dev Cell 25(2):207–219
Schonke M et al (2015) Skeletal muscle AMP-activated protein kinase gamma1(H151R) overexpression enhances whole body energy homeostasis and insulin sensitivity. Am J Physiol Endocrinol Metab 309(7):E679–E690
Schulz TJ et al (2007) Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab 6(4):280–293
Scott JW et al (2004) CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J Clin Invest 113(2):274–284
Sidhu JS et al (2005) Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Circulation 111(1):21–29
Song XM et al (2002) 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice. Diabetologia 45(1):56–65
Spasic MR et al (2008) Drosophila alicorn is a neuronal maintenance factor protecting against activity-induced retinal degeneration. J Neurosci 28(25):6419–6429
Stapleton D et al (1996) Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271(2):611–614
Steinberg GR et al (2010) Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity. J Biol Chem 285(48):37198–37209
Stenesen D et al (2013) Adenosine nucleotide biosynthesis and AMPK regulate adult life span and mediate the longevity benefit of caloric restriction in flies. Cell Metab 17(1):101–112
Stephenne X et al (2011) Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status. Diabetologia 54(12):3101–3110
Sun G et al (2010) Ablation of AMP-activated protein kinase alpha1 and alpha2 from mouse pancreatic beta cells and RIP2.Cre neurons suppresses insulin release in vivo. Diabetologia 53(5):924–936
Sun G et al (2015) LKB1 and AMPKalpha1 are required in pancreatic alpha cells for the normal regulation of glucagon secretion and responses to hypoglycemia. Mol Metab 4(4):277–286
Sung MM et al (2015) AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism. Cardiovasc Res 107(2):235–245
Swick LL et al (2013) Isolation of AMP-activated protein kinase (AMPK) alleles required for neuronal maintenance in Drosophila melanogaster. Biol Open 2(12):1321–1323
Tamas P et al (2006) Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. J Exp Med 203(7):1665–1670
Thornton C et al (1998) Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle. J Biol Chem 273(20):12443–12450
Tohyama D, Yamaguchi A (2010) A critical role of SNF1A/dAMPKalpha (Drosophila AMP-activated protein kinase alpha) in muscle on longevity and stress resistance in Drosophila melanogaster. Biochem Biophys Res Commun 394(1):112–118
Tower J (2000) Transgenic methods for increasing Drosophila life span. Mech Ageing Dev 118(1–2):1–14
Treebak JT et al (2006) AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 55(7):2051–2058
Tschape JA et al (2002) The neurodegeneration mutant lochrig interferes with cholesterol homeostasis and Appl processing. EMBO J 21(23):6367–6376
Tullet JM et al (2014) DAF-16/FoxO directly regulates an atypical AMP-activated protein kinase gamma isoform to mediate the effects of insulin/IGF-1 signaling on aging in Caenorhabditis elegans. PLoS Genet 10(2), e1004109
Ulgherait M et al (2014) AMPK modulates tissue and organismal aging in a non-cell-autonomous manner. Cell Rep 8(6):1767–1780
Vichaiwong K et al (2010) Contraction regulates site-specific phosphorylation of TBC1D1 in skeletal muscle. Biochem J 431(2):311–320
Viollet B et al (2003) The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111(1):91–98
Viollet B et al (2009) AMPK: lessons from transgenic and knockout animals. Front Biosci (Landmark Ed) 14:19–44
Wang S et al (2010) AMPKalpha1 deletion shortens erythrocyte life span in mice: role of oxidative stress. J Biol Chem 285(26):19976–19985
Wang S et al (2015) Resveratrol induces brown-like adipocyte formation in white fat through activation of AMP-activated protein kinase (AMPK) alpha1. Int J Obes (Lond) 39(6):967–976
Winder WW, Hardie DG (1996) Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 270(2 Pt 1):E299–E304
Winder WW, Hardie DG (1999) AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 277(1 Pt 1):E1–E10
Wojtaszewski JF et al (2000) Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J Physiol 528(Pt 1):221–226
Wolf CM et al (2008) Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations. Circulation 117(2):144–154
Wu J et al (2013) Chemoproteomic analysis of intertissue and interspecies isoform diversity of AMP-activated protein kinase (AMPK). J Biol Chem 288(50):35904–35912
Wu Y et al (2015) Activation of AMPKalpha2 in adipocytes is essential for nicotine-induced insulin resistance in vivo. Nat Med 21(4):373–382
Xing Y et al (2003) Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. J Biol Chem 278(31):28372–28377
Yang J et al (2008) Chronic activation of AMP-activated protein kinase-alpha1 in liver leads to decreased adiposity in mice. Biochem Biophys Res Commun 370(2):248–253
Yang S et al (2015) Beta-Guanidinopropionic acid extends the lifespan of Drosophila melanogaster via an AMP-activated protein kinase-dependent increase in autophagy. Aging Cell 14(6):1024–1033
Yang C et al (2016) Chondrocyte-specific ablation of AMPKalpha1 does not affect bone development or pathogenesis of osteoarthritis in mice. DNA Cell Biol 35(3):156–162
Yavari A et al (2016) Chronic activation of gamma2 AMPK induces obesity and reduces beta cell function. Cell Metab 23:821–836
Yu H et al (2006) Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation. Am J Physiol 291(3):E557–E565
Zhang BL et al (2013) Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway. J Cardiol 62(4):241–248
Zhang BL et al (2014) Overexpression of G100S mutation in PRKAG2 causes Wolff-Parkinson-White syndrome in zebrafish. Clin Genet 86(3):287–291
Zhu YP et al (2015) Adenosine 5′-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages. J Immunol 194(2):584–594
Zong H et al (2002) AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci U S A 99(25):15983–15987
Zou L et al (2005) N488I mutation of the gamma2-subunit results in bidirectional changes in AMP-activated protein kinase activity. Circ Res 97(4):323–328
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Viollet, B., Foretz, M. (2016). Animal Models to Study AMPK. In: Cordero, M., Viollet, B. (eds) AMP-activated Protein Kinase. Experientia Supplementum, vol 107. Springer, Cham. https://doi.org/10.1007/978-3-319-43589-3_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-43589-3_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43587-9
Online ISBN: 978-3-319-43589-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)